310 likes | 320 Views
Explore key findings from the 2005 Family Planning Annual Report and HIV Prevention Project data trends in relation to HIV/AIDS epidemiology among Title X users. Understand disparities and positivity rates among different demographics.
E N D
Data Trends:FPAR & HIV Prevention Project OPA/OFP HIV Prevention Project Annual Technical Support Conference June 12, 2007 Presented by Kelly Morrison Opdyke, MPH Cicatelli Associates Inc.
Learning Objectives • Describe key findings from the 2005 Family Planning Annual Report (FPAR) • Review epidemiology of HIV/AIDS in relation to Title X users • Examine national and regional OPA HIV Prevention Project data trends • Compare trends in FPAR and HIV Prevention Project data with national trends
Family Planning Annual Report • The only source of annual, uniform reporting by all Title X service grantees • Enables Title X administrators and grantees to: • Monitor program performance • Comply with federal accountability rules • Guide strategic and financial planning • Estimate impact of Title X-supported activities on key reproductive health outcomes • Published reports available online from OPA: http://opa.osophs.dhhs.gov/titlex/ofp_references.html
FPAR 2005: User Demographics • 5,002,961 family planning users • 95% female, 5% male • 66% below 100% of federal poverty level (FPL) • 60% uninsured • 58% under age 25 • 48% racial and/or ethnic minorities
FPAR 2005: Users by Race/Ethnicity N=5,002,961
FPAR 2005: HIV Testing • HIV test volume increased by 14% in 2005 • 607,974 confidential HIV tests • 519,221 tests among females (85% of all tests) • 88,753 tests among males (15% of all tests) • 1,114 positive confidential tests (0.18%) • 13,349 anonymous HIV tests
FPAR 2005: STD and HIV Testing *Confidential HIV Tests Only
HIV/AIDS among Women Nature of the epidemic • Women of color (especially African American women) are the hardest hit • Younger women are more likely to get HIV • AIDS is a common killer, second only to cancer and heart disease for women Most common modes of transmission • Having sex with a man who has HIV • Sharing injection drug works (needles, etc.) Source: CDC HIV/AIDS among Women Fact Sheet, March 2007
HIV/AIDS among Women • Since 1985 the proportion of estimated AIDS cases diagnosed among women has more than tripled, from 8% in 1985 to 27% in 2004. • In 2004, women of color accounted for 80% of all women estimated to be living with AIDS; black women made up 64% of this total. Source: CDC HIV/AIDS among Women Fact Sheet, March 2007
HIV/AIDS among Youth Nature of the epidemic • 13% of the persons diagnosed with HIV or AIDS in 2004 were age 13-24 years • Young people of racial/ethnic minorities are at increased risk for infection through sexual risk behavior (heterosexual and MSM) Risk Factors • Earlier age at sexual initiation • Higher STD rates Source: CDC HIV/AIDS among Youth Fact Sheet, June 2006
HIV/AIDS Diagnoses by Age Source: CDC Surveillance 2004
HIV Prevention Project (HIVPP) GOAL: • To supplement existing Title X grants, in communities with demonstrated high risk for HIV/AIDS, to implement or expand HIV on‑site prevention counseling, testing, and referral services Cycle 1: Oct 2001 – Aug 2004 34 projects 8 PHS regions (19 states) Cycle 2: Sep 2004 – Sep 2007 63 projects 10 PHS regions (27 states)
HIVPP: Outcome Measures • Number of individual HIV counseling sessions • Number of HIV tests by test mode and type • Confidential v. Anonymous • Standard v. Rapid • Number of positive HIV tests • Number of clients returning for test results and post-test counseling • Number of positive clients referred for Tx/care • HIV testing by race & ethnicity • HIV testing by gender & age group
HIVPP: Counseling Sessions Cycle 1, Periods 1-5 (Oct-01 to Aug-04) and Cycle 2, Periods 1-4 (Sep-04 to Dec-06)
Cycle 2 Cycle 1 HIVPP: Counseling Sessions Cycle 1, Periods 1-5 (Oct-01 to Aug-04) and Cycle 2, Periods 1-4 (Sep-04 to Dec-06)
HIVPP: HIV Tests by Period Cycle 1, Periods 1-5 (Oct-01 to Aug-04) and Cycle 2, Periods 1-4 (Sep-04 to Dec-6)
HIVPP: HIV Tests by Test Mode Cycle 2 Cycle 1 Cycle 1, Periods 1-5 (Oct-01 to Aug-04) and Cycle 2, Periods 1-4 (Sep-04 to Dec-06)
HIVPP: HIV Tests by Test Type %Rapid C2P1: 20% C2P2: 31% C2P3: 41% C2P4: 46% Cycle 2, Periods 1-4: Sep-04 to Dec-06
HIVPP: Return Rate by Test Type Cycle 2, Periods 2-4: July-05 to Dec-06
HIVPP: Testing by Race/Ethnicity Cycle 2, Periods 2-4: July-05 to Dec-06
HIVPP: Positivity by Race/Ethnicity Cycle 2, Periods 2-4: July-05 to Dec-06
HIVPP: Testing by Race/Ethnicity Cycle 2, Periods 2-4: July-05 to Dec-06
HIVPP: Testing by Gender Cycle 2, Periods 1-4: Sep-04 to Dec-06
HIVPP: Testing by Age Group Cycle 2, Periods 2-4: July-05 to Dec-06
HIVPP: Positivity by Region Cycle 2, Periods 1-4: Sep-04 to Dec-06
Summary • HIV testing among FP users is increasing steadily (especially rapid testing) • Racial/ethnic disparities persist, especially among Black/African American users • The HIV positivity rate (>1 per 1,000 tests) in family planning clinics in most regions appears to be cost-effective • HIV prevention strategies should continue to emphasize the importance of the reduction of sexual risk behavior to prevent the spread of infection